Consonance Capital Management as of June 30, 2017
Portfolio Holdings for Consonance Capital Management
Consonance Capital Management holds 20 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amarin Corporation (AMRN) | 11.8 | $100M | 25M | 4.03 | |
| Globus Med Inc cl a (GMED) | 11.1 | $94M | 2.8M | 33.15 | |
| Myriad Genetics (MYGN) | 9.9 | $84M | 3.3M | 25.84 | |
| Advanced Accelerat spon ads each rep 2 ord | 8.6 | $73M | 1.9M | 39.04 | |
| Ptc Therapeutics I (PTCT) | 8.5 | $72M | 3.9M | 18.33 | |
| AtriCure (ATRC) | 8.1 | $69M | 2.8M | 24.25 | |
| Corcept Therapeutics Incorporated (CORT) | 8.1 | $69M | 5.8M | 11.80 | |
| La Jolla Pharmaceuticl Com Par | 7.1 | $60M | 2.0M | 29.77 | |
| Clovis Oncology | 6.0 | $51M | 545k | 93.63 | |
| Keryx Biopharmaceuticals | 6.0 | $51M | 7.0M | 7.23 | |
| Retrophin | 5.6 | $47M | 2.4M | 19.39 | |
| Corindus Vascular Robotics I | 3.3 | $28M | 15M | 1.86 | |
| Spectrum Pharmaceuticals | 1.8 | $15M | 2.0M | 7.45 | |
| Pacific Biosciences of California (PACB) | 1.6 | $14M | 3.8M | 3.56 | |
| Vericel (VCEL) | 1.0 | $8.5M | 2.6M | 3.30 | |
| Biosante Pharmaceuticals (ANIP) | 0.8 | $6.7M | 143k | 46.80 | |
| Adma Biologics (ADMA) | 0.6 | $4.7M | 1.3M | 3.70 | |
| Biolase Technology | 0.1 | $1.1M | 1.2M | 0.97 | |
| Seaspine Holdings | 0.1 | $618k | 54k | 11.52 | |
| Strongbridge Bioph shs usd | 0.0 | $72k | 10k | 7.20 |
